Skip to main content
SpringerLink
Log in

Initial clinical experience with a new peripheral vasodilator, PR-G-138-Cl, in hypertensive patients

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

PR-G-138-Cl, a new antihypertensive agent with vasodilating properties, was studied in ten patients with moderate to severe hypertension. The patients were admitted to a metabolic ward and followed on a 2 gm salt diet. Placebo was given daily until blood pressure and weight were stabilized. A dose titration was then started with increasing single daily doses of 3, 5, 8, and 10 mg of PR-G-138-Cl orally. The dose at which the mean arterial pressure was reduced by 15 mm Hg was continued for a total of seven days. PR-G-138-Cl lowered sitting mean arterial pressures significantly in all subjects (133.8±15.1 → 116.0±12.4 mm Hg, p<0.001). The antihypertensive effect was first noted 30 minutes following drug administration and persisted for as long as six hours with a peak effect at one hour. All patients had a significant increase in sitting pulse rate (80.4±9.11 → 90.0 ±6.91/min, p<0.002). Blood pressure reduction and increase in pulse rate were dose related. The most common side effects noted were headaches in eight out of ten patients and postural dizziness in seven out of ten patients. There were no signs of fluid retention (weight gain or edema). Electrocardiogram and other laboratory parameters remained essentially unchanged.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. New vasodilator drugs in hypertension. Brit. med. J.1973 IV 185–186

    Google Scholar 

  2. Koch-Weser, J.: Vasodilator drugs in the treatment of hypertension. Arch. intern. Med.133 1007–1027 (1974)

    Google Scholar 

  3. Page, I.H., Corcoran, A.C., Dustan, H.P., Koppanyi, T.: Cardiovascular action of sodium nitroprusside in animals and hypertensive patients. Circulation11 188–198 (1955)

    Google Scholar 

  4. Ahearn, D.J.: Treatment of malignant hypertension with sodium nitroprusside. Arch. intern. Med.133 187–191 (1974)

    Google Scholar 

  5. Moyer, J.H.: Hydralazine (apresoline) hydrochloride: Pharmacological oberservations and clinical results in the therapy of hypertension. Arch. intern. Med.91 419.439 (1953)

    Google Scholar 

  6. Finnerty, Jr., F.A., Kakaviatos, N., Tuckman, J., Magill, J.: Clinical evaluation of diazoxide, a new treatment for hypertension. Circulation28 203–208 (1963)

    Google Scholar 

  7. Pettinger, W.A., Mitchell, H.C.: Minoxidil, an alternative to nephrectomy for refractory hypertension. New Engl. J. Med.289 167–173 (1973)

    Google Scholar 

  8. Hammer, J., Ulrych, M., Freis, E.D.: Hemodynamic and therapeutic effect of guancydine in hypertension. Clin. Pharmacol. Ther.12 78–90 (1971)

    Google Scholar 

  9. Lewis, P.J., George, C.F., Dollery, C.T.: Clinical evaluation of indoramin, a new antihypertensive agent. Europ. J. clin. Pharmacol.6 211–216 (1973)

    Google Scholar 

  10. Zacest, R., Gilmore, E., Koch-Weser, J.: Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade. New Engl. J. Med.288 617–622 (1972)

    Google Scholar 

  11. Gottlieb, T.B., Katz, F.H., Chidsey, III, C.A.: Combined therapy with vasodilator drug and beta adrenergic blockade in hypertension, a comparative study of minoxidil and hydralazine. Circulation45 551–583 (1972)

    Google Scholar 

  12. Alarćon-Sergovia, D., Wakin, K.G., Worthington, J.W., Ward, L.E.: Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus. Medicine (Baltimore)46 1–33 (1967)

    Google Scholar 

  13. Muller, S.A.: Hirsuitism. Amer. J. Med.46 803–817 (1969)

    Google Scholar 

  14. Durcharme, D.W., Freyburger, W.A., Graham, B.F., Carlson, R.G.: Pharmacologic properties of minoxidil: A new hypotensive agent. J. Pharmacol. exp. Ther.184 662–670 (1973)

    Google Scholar 

  15. Götz, M., Grotzinger, K.: 3-Hydroxysydnoneimines. Tetrahedron27 4449–4456 (1971)

    Google Scholar 

  16. Oliver, J.T.: Unpublished data.

  17. Hollander, M., Wolfe, D.A.: Nonparametric statistical methods, pp. 138–158. New York: John Wiley and Sons 1973

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Therapeutics Section, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA

    H. P. Blumenthal, J. R. Ryan & F. G. McMahon

Authors
  1. H. P. Blumenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. R. Ryan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. G. McMahon
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

PR-G-138-Cl and identical appearing placebo capsules were supplied by Pharma-Research Canada, Ltd., Montreal, Canada.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blumenthal, H.P., Ryan, J.R. & McMahon, F.G. Initial clinical experience with a new peripheral vasodilator, PR-G-138-Cl, in hypertensive patients. Eur J Clin Pharmacol 8, 409–414 (1975). https://doi.org/10.1007/BF00562314

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00562314

Key words

Search

Navigation